Logo image of NMAX

NEWSMAX INC (NMAX) Stock Fundamental Analysis

USA - NYSE:NMAX - US65250K1051 - Common Stock

10.25 USD
-0.57 (-5.27%)
Last: 10/27/2025, 8:04:01 PM
10.3 USD
+0.05 (+0.49%)
Pre-Market: 10/28/2025, 8:21:45 AM
Fundamental Rating

3

Taking everything into account, NMAX scores 3 out of 10 in our fundamental rating. NMAX was compared to 94 industry peers in the Media industry. NMAX has a great financial health rating, but its profitability evaluates not so good. While showing a medium growth rate, NMAX is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

NMAX had negative earnings in the past year.
In the past year NMAX has reported a negative cash flow from operations.
NMAX Yearly Net Income VS EBIT VS OCF VS FCFNMAX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 -20M -40M -60M -80M

1.2 Ratios

NMAX has a worse Return On Assets (-30.86%) than 78.72% of its industry peers.
The Return On Equity of NMAX (-75.04%) is worse than 69.15% of its industry peers.
Industry RankSector Rank
ROA -30.86%
ROE -75.04%
ROIC N/A
ROA(3y)-53.26%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NMAX Yearly ROA, ROE, ROICNMAX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 200 -200 400 600 800

1.3 Margins

NMAX has a Gross Margin (49.15%) which is comparable to the rest of the industry.
NMAX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 49.15%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NMAX Yearly Profit, Operating, Gross MarginsNMAX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 20 -20 40 -40

7

2. Health

2.1 Basic Checks

NMAX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for NMAX remains at a similar level compared to 1 year ago.
NMAX has a better debt/assets ratio than last year.
NMAX Yearly Shares OutstandingNMAX Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 20M 40M 60M 80M 100M
NMAX Yearly Total Debt VS Total AssetsNMAX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 50M 100M

2.2 Solvency

An Altman-Z score of 3.89 indicates that NMAX is not in any danger for bankruptcy at the moment.
NMAX has a better Altman-Z score (3.89) than 87.23% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that NMAX is not too dependend on debt financing.
NMAX has a Debt to Equity ratio of 0.00. This is amongst the best in the industry. NMAX outperforms 89.36% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 3.89
ROIC/WACCN/A
WACC8.66%
NMAX Yearly LT Debt VS Equity VS FCFNMAX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 -20M -40M

2.3 Liquidity

NMAX has a Current Ratio of 2.50. This indicates that NMAX is financially healthy and has no problem in meeting its short term obligations.
NMAX has a Current ratio of 2.50. This is amongst the best in the industry. NMAX outperforms 85.11% of its industry peers.
NMAX has a Quick Ratio of 2.48. This indicates that NMAX is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 2.48, NMAX belongs to the best of the industry, outperforming 85.11% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.5
Quick Ratio 2.48
NMAX Yearly Current Assets VS Current LiabilitesNMAX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 20M 40M 60M 80M 100M

4

3. Growth

3.1 Past

NMAX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -68.55%.
NMAX shows a strong growth in Revenue. In the last year, the Revenue has grown by 26.42%.
EPS 1Y (TTM)-68.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-28.48%
Revenue 1Y (TTM)26.42%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-41.83%

3.2 Future

The Earnings Per Share is expected to grow by 27.01% on average over the next years. This is a very strong growth
Based on estimates for the next years, NMAX will show a quite strong growth in Revenue. The Revenue will grow by 11.35% on average per year.
EPS Next Y-18.23%
EPS Next 2Y38.21%
EPS Next 3Y27.01%
EPS Next 5YN/A
Revenue Next Year7.53%
Revenue Next 2Y10.86%
Revenue Next 3Y11.35%
Revenue Next 5YN/A

3.3 Evolution

NMAX Yearly Revenue VS EstimatesNMAX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M
NMAX Yearly EPS VS EstimatesNMAX Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 0 -0.2 -0.4 -0.6

1

4. Valuation

4.1 Price/Earnings Ratio

NMAX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NMAX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NMAX Price Earnings VS Forward Price EarningsNMAX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100 -150

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NMAX Per share dataNMAX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1

4.3 Compensation for Growth

A more expensive valuation may be justified as NMAX's earnings are expected to grow with 27.01% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.21%
EPS Next 3Y27.01%

0

5. Dividend

5.1 Amount

NMAX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

NEWSMAX INC

NYSE:NMAX (10/27/2025, 8:04:01 PM)

Premarket: 10.3 +0.05 (+0.49%)

10.25

-0.57 (-5.27%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)08-19 2025-08-19/amc
Earnings (Next)N/A N/A
Inst Owners29.39%
Inst Owner Change0.21%
Ins OwnersN/A
Ins Owner Change0%
Market Cap1.32B
Revenue(TTM)171.02M
Net Income(TTM)-80177700
Analysts82.5
Price Target21.93 (113.95%)
Short Float %3.09%
Short Ratio2.61
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.28%
Min Revenue beat(2)-1.96%
Max Revenue beat(2)1.4%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)N/A
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 7.73
P/FCF N/A
P/OCF N/A
P/B 12.38
P/tB 12.38
EV/EBITDA N/A
EPS(TTM)-0.63
EYN/A
EPS(NY)-0.06
Fwd EYN/A
FCF(TTM)-0.63
FCFYN/A
OCF(TTM)-0.62
OCFYN/A
SpS1.33
BVpS0.83
TBVpS0.83
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -30.86%
ROE -75.04%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 49.15%
FCFM N/A
ROA(3y)-53.26%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.66
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 24.2%
Cap/Sales 0.86%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.5
Quick Ratio 2.48
Altman-Z 3.89
F-Score4
WACC8.66%
ROIC/WACCN/A
Cap/Depr(3y)90.3%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.87%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-68.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-28.48%
EPS Next Y-18.23%
EPS Next 2Y38.21%
EPS Next 3Y27.01%
EPS Next 5YN/A
Revenue 1Y (TTM)26.42%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-41.83%
Revenue Next Year7.53%
Revenue Next 2Y10.86%
Revenue Next 3Y11.35%
Revenue Next 5YN/A
EBIT growth 1Y-229.8%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year79.59%
EBIT Next 3Y28.86%
EBIT Next 5YN/A
FCF growth 1Y-946.3%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1170.71%
OCF growth 3YN/A
OCF growth 5YN/A

NEWSMAX INC / NMAX FAQ

Can you provide the ChartMill fundamental rating for NEWSMAX INC?

ChartMill assigns a fundamental rating of 3 / 10 to NMAX.


What is the valuation status for NMAX stock?

ChartMill assigns a valuation rating of 1 / 10 to NEWSMAX INC (NMAX). This can be considered as Overvalued.


What is the profitability of NMAX stock?

NEWSMAX INC (NMAX) has a profitability rating of 0 / 10.


How financially healthy is NEWSMAX INC?

The financial health rating of NEWSMAX INC (NMAX) is 7 / 10.